Stockreport

COLLPLANT BIOTECHNOLOGIES REPORTS 2024 FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE [Yahoo! Finance]

CollPlant Biotechnologies Ltd. - Ordinary Shares  (CLGN) 
US:NASDAQ Investor Relations: collplant.com/investor-relation
PDF aesthetic or medical purposes and aims to address a $3 billion market opportunity Recently received a $2 million development payment from AbbVie Conference call to b [Read more]